| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | MAK PSKH1 IRAK1 HUNK ITK MAP3K3 PHKA1 CDKL5 STK10 BMX MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 PRKAG3 CSNK1E MAP4K5 MAP4K1 ROCK1 PRKDC ATM MAPK6 PSKH2 EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 6.71e-12 | 600 | 238 | 31 | GO:0004672 |
| GeneOntologyMolecularFunction | kinase activity | MAK PSKH1 IRAK1 AK9 HUNK ITK MAP3K3 PHKA1 CDKL5 STK10 BMX PIK3CD MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 PRKAG3 TK2 CSNK1E MAP4K5 MAP4K1 ROCK1 PRKDC ATM MAPK6 PSKH2 EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 3.52e-11 | 764 | 238 | 34 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | MAK PSKH1 IRAK1 HUNK ITK MAP3K3 PHKA1 CDKL5 STK10 BMX PIK3CD MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 PRKAG3 CSNK1E MAP4K5 MAP4K1 ROCK1 PRKDC ATM MAPK6 PSKH2 EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 9.89e-11 | 709 | 238 | 32 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | MAK PSKH1 IRAK1 HUNK MAP3K3 CDKL5 STK10 MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 CSNK1E MAP4K5 MAP4K1 ROCK1 PRKDC ATM MAPK6 PSKH2 | 4.83e-10 | 363 | 238 | 22 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MAK PSKH1 IRAK1 HUNK MAP3K3 PHKA1 CDKL5 STK10 MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 PRKAG3 CSNK1E MAP4K5 MAP4K1 ROCK1 PRKDC ATM MAPK6 PSKH2 | 8.38e-10 | 446 | 238 | 24 | GO:0004674 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | MAK PSKH1 IRAK1 AK9 HUNK ITK MAP3K3 PHKA1 CDKL5 STK10 BMX PIK3CD MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 PRKAG3 POLR3B TK2 CSNK1E MAP4K5 MAP4K1 ROCK1 PRKDC ATM MAPK6 PSKH2 EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 1.99e-09 | 938 | 238 | 35 | GO:0016772 |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.01e-07 | 11 | 238 | 5 | GO:0008503 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 2.90e-07 | 6 | 238 | 4 | GO:0008349 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 6.28e-07 | 15 | 238 | 5 | GO:0005005 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | SLC22A8 CLCN7 SLC25A27 SLC17A4 ADAMTS8 ANO8 SLC26A11 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 1.03e-06 | 171 | 238 | 12 | GO:0015103 |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.74e-06 | 18 | 238 | 5 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 2.34e-06 | 19 | 238 | 5 | GO:0004890 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 2.34e-06 | 19 | 238 | 5 | GO:0005003 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 5.15e-06 | 22 | 238 | 5 | GO:0016917 | |
| GeneOntologyMolecularFunction | chloride channel activity | 8.63e-06 | 86 | 238 | 8 | GO:0005254 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | CLCN7 SLC25A27 ANO8 SLC26A11 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 1.92e-05 | 125 | 238 | 9 | GO:0015108 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.76e-05 | 50 | 238 | 6 | GO:0099095 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 3.25e-05 | 103 | 238 | 8 | GO:0005253 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 5.65e-05 | 7 | 238 | 3 | GO:0005004 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | CLCN7 SLC25A27 ANO8 SLC26A11 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 8.49e-05 | 151 | 238 | 9 | GO:0008509 |
| GeneOntologyMolecularFunction | arginine binding | 1.33e-04 | 9 | 238 | 3 | GO:0034618 | |
| GeneOntologyMolecularFunction | Rho-dependent protein serine/threonine kinase activity | 1.41e-04 | 2 | 238 | 2 | GO:0072518 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.73e-04 | 24 | 238 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.55e-04 | 145 | 238 | 8 | GO:0004713 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase activity | 4.21e-04 | 3 | 238 | 2 | GO:0004517 | |
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 4.21e-04 | 3 | 238 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 4.21e-04 | 3 | 238 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 5.83e-04 | 57 | 238 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 7.39e-04 | 60 | 238 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | tetrahydrobiopterin binding | 8.36e-04 | 4 | 238 | 2 | GO:0034617 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.06e-03 | 65 | 238 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.06e-03 | 65 | 238 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.06e-03 | 65 | 238 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.20e-03 | 18 | 238 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SCN11A TRPC6 TRPM2 CLCN7 ABCC8 ANO8 SLC26A11 UNC80 CACNA2D3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 1.28e-03 | 459 | 238 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.38e-03 | 5 | 238 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.47e-03 | 103 | 238 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.73e-03 | 144 | 238 | 7 | GO:0016798 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.02e-03 | 75 | 238 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 2.06e-03 | 6 | 238 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | 3'-5' RNA helicase activity | 2.06e-03 | 6 | 238 | 2 | GO:0034458 | |
| GeneOntologyMolecularFunction | ADP-ribose diphosphatase activity | 2.06e-03 | 6 | 238 | 2 | GO:0047631 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.26e-03 | 193 | 238 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.27e-03 | 77 | 238 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | ankyrin binding | 2.48e-03 | 23 | 238 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.57e-03 | 197 | 238 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | chromatin insulator sequence binding | 2.86e-03 | 7 | 238 | 2 | GO:0043035 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ERCC3 CCT3 AK9 STARD9 ABCC8 DNHD1 DNAH3 EP400 RNF213 CHD9 YTHDC2 ORC1 DNAH12 TMEM30A DDX3Y AQR | 2.95e-03 | 614 | 238 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.49e-03 | 85 | 238 | 5 | GO:0019199 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | MAK IRAK1 MAP3K3 CDKL5 STK10 BMX PTPRC MAP3K11 STK24 MAP4K1 ATM EPHA4 EPHA7 EPHA8 EPHB1 | 5.91e-08 | 228 | 235 | 15 | GO:0046777 |
| GeneOntologyBiologicalProcess | inorganic anion transport | SLC22A8 CLCN7 SLC25A27 SLC17A4 ADAMTS8 ANO8 TG SLC26A11 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 1.57e-07 | 180 | 235 | 13 | GO:0015698 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | CLCN7 SLC25A27 ANO8 SLC26A11 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 5.51e-06 | 112 | 235 | 9 | GO:1902476 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | CLCN7 SLC25A27 SLC17A4 ANO8 TG SLC26A11 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 8.48e-06 | 183 | 235 | 11 | GO:0006820 |
| GeneOntologyBiologicalProcess | chloride transport | CLCN7 SLC25A27 ANO8 SLC26A11 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 1.63e-05 | 128 | 235 | 9 | GO:0006821 |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 2.08e-05 | 30 | 235 | 5 | GO:1904862 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | CLCN7 SLC25A27 ANO8 SLC26A11 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 2.36e-05 | 134 | 235 | 9 | GO:0098661 |
| GeneOntologyBiologicalProcess | synapse organization | ACTBL2 NFASC CDKL5 NLGN3 PTPRD SSH1 LRFN5 ROCK2 NRCAM UBE3B NTNG1 ROCK1 CACNA2D3 GABRA1 GABRA2 EPHA4 GABRA3 GABRA4 EPHA7 GABRA5 EPHB1 | 4.06e-05 | 685 | 235 | 21 | GO:0050808 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 4.52e-05 | 35 | 235 | 5 | GO:0007214 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | CLCN7 SLC25A27 ANO8 SLC26A11 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 6.68e-05 | 153 | 235 | 9 | GO:0098656 |
| GeneOntologyBiologicalProcess | cell junction organization | ACTBL2 MTSS1 NFASC RCC2 CDKL5 NLGN3 CDH20 PTPRD SSH1 LRFN5 ABCC8 ROCK2 NRCAM UBE3B NTNG1 ROCK1 CACNA2D3 GABRA1 GABRA2 EPHA4 GABRA3 GABRA4 EPHA7 GABRA5 EPHB1 | 1.33e-04 | 974 | 235 | 25 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SCN11A ACTBL2 TRPC6 NFASC CDKL5 NLGN3 PTPRD PCDH15 VASP FOXG1 ROCK2 NRCAM SZT2 LAMA2 NTNG1 ENAH EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 1.40e-04 | 748 | 235 | 21 | GO:0048667 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.83e-06 | 19 | 237 | 5 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 3.15e-06 | 21 | 237 | 5 | GO:1902710 | |
| GeneOntologyCellularComponent | leading edge membrane | CDKL5 FAP BMX VASP PACSIN2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 PSD4 | 2.94e-05 | 210 | 237 | 11 | GO:0031256 |
| GeneOntologyCellularComponent | chloride channel complex | 4.46e-05 | 57 | 237 | 6 | GO:0034707 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | NLGN3 LRFN5 NRCAM GABRA1 GABRA2 EPHA4 GABRA3 GABRA4 EPHA7 GABRA5 | 1.04e-04 | 201 | 237 | 10 | GO:0099634 |
| GeneOntologyCellularComponent | GABA-ergic synapse | NLGN3 LRFN5 SYT7 CACNA2D3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 1.10e-04 | 164 | 237 | 9 | GO:0098982 |
| GeneOntologyCellularComponent | inner dynein arm | 1.63e-04 | 10 | 237 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | cell leading edge | MTSS1 CDKL5 FAP BMX SSH1 VASP SRA1 ENAH ROCK1 PACSIN2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 PSD4 | 2.01e-04 | 500 | 237 | 16 | GO:0031252 |
| GeneOntologyCellularComponent | presynaptic membrane | SCN11A PTPRD CLTC NTNG1 SYT7 UNC13C CACNA2D3 GABRA2 EPHA4 GABRA3 GABRA5 | 3.40e-04 | 277 | 237 | 11 | GO:0042734 |
| GeneOntologyCellularComponent | synaptic membrane | SCN11A NLGN3 PTPRD LRFN5 CLTC NRCAM NTNG1 SYT7 UNC13C CACNA2D3 GABRA1 GABRA2 EPHA4 GABRA3 GABRA4 EPHA7 GABRA5 | 3.76e-04 | 583 | 237 | 17 | GO:0097060 |
| GeneOntologyCellularComponent | t-UTP complex | 3.81e-04 | 3 | 237 | 2 | GO:0034455 | |
| GeneOntologyCellularComponent | dendrite membrane | 4.28e-04 | 56 | 237 | 5 | GO:0032590 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 1.03e-03 | 179 | 237 | 8 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 1.03e-03 | 179 | 237 | 8 | GO:0030672 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.15e-03 | 141 | 237 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | cell projection membrane | CDKL5 FAP BMX VASP ANPEP SLC17A4 PACSIN2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 PSD4 | 1.35e-03 | 431 | 237 | 13 | GO:0031253 |
| GeneOntologyCellularComponent | dendrite | NFASC CDKL5 NLGN3 SACS PPP1R2P1 NOS1 ICA1 LAMA2 SYT7 PPP1R2 EPHA10 GABRA1 GABRA2 EPHA4 GABRA3 GABRA4 EPHA7 GABRA5 EPHA8 EPHB1 | 1.91e-03 | 858 | 237 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | NFASC CDKL5 NLGN3 SACS PPP1R2P1 NOS1 ICA1 LAMA2 SYT7 PPP1R2 EPHA10 GABRA1 GABRA2 EPHA4 GABRA3 GABRA4 EPHA7 GABRA5 EPHA8 EPHB1 | 1.96e-03 | 860 | 237 | 20 | GO:0097447 |
| MousePheno | abnormal GABA-mediated receptor currents | 2.79e-06 | 18 | 184 | 5 | MP:0004008 | |
| MousePheno | increased central memory CD4-positive, alpha-beta T cell number | 1.30e-05 | 24 | 184 | 5 | MP:0010841 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell number | 4.08e-05 | 30 | 184 | 5 | MP:0012771 | |
| MousePheno | abnormal central memory CD4-positive, alpha-beta T cell morphology | 4.08e-05 | 30 | 184 | 5 | MP:0010840 | |
| MousePheno | increased mature B cell number | 7.63e-05 | 168 | 184 | 10 | MP:0008210 | |
| MousePheno | abnormal CD4-positive, alpha-beta memory T cell morphology | 8.13e-05 | 55 | 184 | 6 | MP:0010834 | |
| MousePheno | increased B-1 B cell number | 1.21e-04 | 59 | 184 | 6 | MP:0004977 | |
| MousePheno | increased CD4-positive, alpha-beta memory T cell number | 1.21e-04 | 59 | 184 | 6 | MP:0010835 | |
| MousePheno | increased effector memory CD4-positive, alpha-beta T cell number | 1.91e-04 | 41 | 184 | 5 | MP:0010844 | |
| MousePheno | increased immunoglobulin level | PTPN22 RO60 ITK PTPRC PIK3CD NOS2 IRF8 LAMA2 RGS13 TG MAP4K5 PRKDC ATM | 2.02e-04 | 305 | 184 | 13 | MP:0002461 |
| MousePheno | abnormal B-1 B cell number | 2.08e-04 | 122 | 184 | 8 | MP:0004976 | |
| MousePheno | abnormal central memory CD8-positive, alpha-beta T cell number | 2.14e-04 | 42 | 184 | 5 | MP:0012772 | |
| MousePheno | abnormal central memory CD8 positive, alpha-beta T cell morphology | 2.14e-04 | 42 | 184 | 5 | MP:0010846 | |
| MousePheno | abnormal B-1 B cell morphology | 2.20e-04 | 123 | 184 | 8 | MP:0004940 | |
| Domain | Kinase-like_dom | MAK PSKH1 IRAK1 HUNK ITK MAP3K3 CDKL5 STK10 BMX PIK3CD MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 CHD9 CSNK1E MAP4K5 MAP4K1 ROCK1 PRKDC ATM MAPK6 PSKH2 EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 1.49e-12 | 542 | 233 | 31 | IPR011009 |
| Domain | Protein_kinase_ATP_BS | MAK PSKH1 IRAK1 HUNK ITK CDKL5 STK10 BMX MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 CSNK1E MAP4K5 MAP4K1 ROCK1 MAPK6 PSKH2 EPHA4 EPHA7 EPHA8 EPHB1 | 1.22e-11 | 379 | 233 | 25 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | MAK PSKH1 IRAK1 HUNK ITK MAP3K3 CDKL5 STK10 BMX MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 CSNK1E MAP4K5 MAP4K1 ROCK1 MAPK6 PSKH2 EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 2.45e-11 | 459 | 233 | 27 | PS00107 |
| Domain | Prot_kinase_dom | MAK PSKH1 IRAK1 HUNK ITK MAP3K3 CDKL5 STK10 BMX MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 CSNK1E MAP4K5 MAP4K1 ROCK1 MAPK6 PSKH2 EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 1.03e-10 | 489 | 233 | 27 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MAK PSKH1 IRAK1 HUNK ITK MAP3K3 CDKL5 STK10 BMX MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 CSNK1E MAP4K5 MAP4K1 ROCK1 MAPK6 PSKH2 EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 1.23e-10 | 493 | 233 | 27 | PS50011 |
| Domain | GABAAa_rcpt | 1.72e-09 | 6 | 233 | 5 | IPR001390 | |
| Domain | MAPKKKK | 2.36e-08 | 4 | 233 | 4 | IPR021160 | |
| Domain | Ser/Thr_kinase_AS | MAK PSKH1 IRAK1 HUNK MAP3K3 CDKL5 STK10 MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 CSNK1E MAP4K5 MAP4K1 ROCK1 MAPK6 PSKH2 | 2.43e-08 | 357 | 233 | 20 | IPR008271 |
| Domain | S_TKc | MAK PSKH1 IRAK1 HUNK MAP3K3 CDKL5 STK10 MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 MAP4K5 MAP4K1 ROCK1 MAPK6 PSKH2 EPHA4 | 2.67e-08 | 359 | 233 | 20 | SM00220 |
| Domain | PROTEIN_KINASE_ST | MAK PSKH1 IRAK1 HUNK MAP3K3 CDKL5 STK10 MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 CSNK1E MAP4K5 MAP4K1 ROCK1 MAPK6 PSKH2 | 3.07e-08 | 362 | 233 | 20 | PS00108 |
| Domain | Pkinase | MAK PSKH1 IRAK1 HUNK MAP3K3 CDKL5 STK10 MAP3K11 STK24 MAP4K2 ROCK2 MAP4K3 HIPK2 CILK1 CSNK1E MAP4K5 MAP4K1 ROCK1 MAPK6 PSKH2 | 7.11e-08 | 381 | 233 | 20 | PF00069 |
| Domain | - | 3.04e-07 | 73 | 233 | 9 | 2.60.120.260 | |
| Domain | Ephrin_rec_like | 5.13e-07 | 25 | 233 | 6 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 5.13e-07 | 25 | 233 | 6 | IPR011641 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 5.29e-07 | 14 | 233 | 5 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 5.29e-07 | 14 | 233 | 5 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 5.29e-07 | 14 | 233 | 5 | IPR001426 | |
| Domain | EphA2_TM | 5.29e-07 | 14 | 233 | 5 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 5.29e-07 | 14 | 233 | 5 | IPR001090 | |
| Domain | Eph_TM | 5.29e-07 | 14 | 233 | 5 | IPR027936 | |
| Domain | EPH_lbd | 5.29e-07 | 14 | 233 | 5 | SM00615 | |
| Domain | Ephrin_lbd | 5.29e-07 | 14 | 233 | 5 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 5.29e-07 | 14 | 233 | 5 | IPR016257 | |
| Domain | EPH_LBD | 5.29e-07 | 14 | 233 | 5 | PS51550 | |
| Domain | TF_fork_head_CS_2 | 1.52e-06 | 46 | 233 | 7 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 1.77e-06 | 47 | 233 | 7 | IPR018122 | |
| Domain | FH | 2.36e-06 | 49 | 233 | 7 | SM00339 | |
| Domain | FORK_HEAD_1 | 2.36e-06 | 49 | 233 | 7 | PS00657 | |
| Domain | FORK_HEAD_2 | 2.36e-06 | 49 | 233 | 7 | PS00658 | |
| Domain | Fork_head_dom | 2.36e-06 | 49 | 233 | 7 | IPR001766 | |
| Domain | FORK_HEAD_3 | 2.36e-06 | 49 | 233 | 7 | PS50039 | |
| Domain | Forkhead | 2.36e-06 | 49 | 233 | 7 | PF00250 | |
| Domain | Galactose-bd-like | 2.66e-06 | 94 | 233 | 9 | IPR008979 | |
| Domain | GABAA/Glycine_rcpt | 8.11e-06 | 23 | 233 | 5 | IPR006028 | |
| Domain | Tyr_kinase_cat_dom | 1.42e-05 | 88 | 233 | 8 | IPR020635 | |
| Domain | TyrKc | 1.42e-05 | 88 | 233 | 8 | SM00219 | |
| Domain | CNH | 2.14e-05 | 14 | 233 | 4 | SM00036 | |
| Domain | CNH | 2.89e-05 | 15 | 233 | 4 | PF00780 | |
| Domain | CNH | 2.89e-05 | 15 | 233 | 4 | PS50219 | |
| Domain | CNH_dom | 2.89e-05 | 15 | 233 | 4 | IPR001180 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 5.96e-05 | 138 | 233 | 9 | IPR001245 | |
| Domain | - | FOXI3 FOXG1 FOXI1 FOXE3 FOXD2 IRF8 RFX7 ORC1 FOXD3 FOXI2 PAX1 | 9.61e-05 | 218 | 233 | 11 | 1.10.10.10 |
| Domain | ARM-type_fold | MON2 NBEAL1 INTS1 ELMO1 PIK3CD CLTC TNPO1 DOCK2 MROH9 FHOD3 HEATR1 MROH2B PRKDC ATM | 9.68e-05 | 339 | 233 | 14 | IPR016024 |
| Domain | Rho_Binding | 1.55e-04 | 2 | 233 | 2 | PF08912 | |
| Domain | Rho-bd_dom | 1.55e-04 | 2 | 233 | 2 | IPR015008 | |
| Domain | ROCK1/ROCK2 | 1.55e-04 | 2 | 233 | 2 | IPR020684 | |
| Domain | fn3 | 2.03e-04 | 162 | 233 | 9 | PF00041 | |
| Domain | FN3 | NFASC PTPRC PTPRD LRFN5 NRCAM EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 2.06e-04 | 199 | 233 | 10 | PS50853 |
| Domain | PROTEIN_KINASE_TYR | 2.13e-04 | 97 | 233 | 7 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.13e-04 | 97 | 233 | 7 | IPR008266 | |
| Domain | Pkinase_Tyr | 2.17e-04 | 129 | 233 | 8 | PF07714 | |
| Domain | Neurotransmitter_ion_chnl_CS | 2.35e-04 | 45 | 233 | 5 | IPR018000 | |
| Domain | WHTH_DNA-bd_dom | FOXI3 FOXG1 FOXI1 FOXE3 FOXD2 IRF8 RFX7 ORC1 FOXD3 FOXI2 PAX1 | 2.40e-04 | 242 | 233 | 11 | IPR011991 |
| Domain | Neur_chan_memb | 2.62e-04 | 46 | 233 | 5 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 2.90e-04 | 47 | 233 | 5 | IPR006029 | |
| Domain | - | 2.90e-04 | 47 | 233 | 5 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 2.90e-04 | 47 | 233 | 5 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 2.90e-04 | 47 | 233 | 5 | PS00236 | |
| Domain | Neur_channel | 2.90e-04 | 47 | 233 | 5 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.90e-04 | 47 | 233 | 5 | IPR006202 | |
| Domain | FN3_dom | NFASC PTPRC PTPRD LRFN5 NRCAM EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 3.05e-04 | 209 | 233 | 10 | IPR003961 |
| Domain | VASP_tetra | 4.61e-04 | 3 | 233 | 2 | PF08776 | |
| Domain | NO_synthase | 4.61e-04 | 3 | 233 | 2 | PF02898 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 4.61e-04 | 3 | 233 | 2 | IPR006794 | |
| Domain | NOS_euk | 4.61e-04 | 3 | 233 | 2 | IPR012144 | |
| Domain | VASP_tetra | 4.61e-04 | 3 | 233 | 2 | IPR014885 | |
| Domain | - | 4.61e-04 | 3 | 233 | 2 | 3.90.340.10 | |
| Domain | Zfx_Zfy_act | 4.61e-04 | 3 | 233 | 2 | PF04704 | |
| Domain | NOS_N | 4.61e-04 | 3 | 233 | 2 | IPR004030 | |
| Domain | NOS | 4.61e-04 | 3 | 233 | 2 | PS60001 | |
| Domain | FN3 | 5.39e-04 | 185 | 233 | 9 | SM00060 | |
| Domain | Dynein_heavy_dom-2 | 6.30e-04 | 14 | 233 | 3 | IPR013602 | |
| Domain | DHC_N2 | 6.30e-04 | 14 | 233 | 3 | PF08393 | |
| Domain | DHC_fam | 7.81e-04 | 15 | 233 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 7.81e-04 | 15 | 233 | 3 | PF03028 | |
| Domain | PI3/4_kinase_CS | 7.81e-04 | 15 | 233 | 3 | IPR018936 | |
| Domain | Dynein_heavy_dom | 7.81e-04 | 15 | 233 | 3 | IPR004273 | |
| Domain | Neurofascin/L1/NrCAM_C | 9.15e-04 | 4 | 233 | 2 | IPR026966 | |
| Domain | Lys_sp_deMease-like_dom | 9.15e-04 | 4 | 233 | 2 | IPR013637 | |
| Domain | PLU-1 | 9.15e-04 | 4 | 233 | 2 | PF08429 | |
| Domain | Bravo_FIGEY | 9.15e-04 | 4 | 233 | 2 | PF13882 | |
| Domain | - | 9.52e-04 | 16 | 233 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 9.52e-04 | 16 | 233 | 3 | SM00146 | |
| Domain | PTPc | 1.02e-03 | 36 | 233 | 4 | SM00194 | |
| Domain | PI3_PI4_kinase | 1.36e-03 | 18 | 233 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 1.36e-03 | 18 | 233 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.36e-03 | 18 | 233 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 1.36e-03 | 18 | 233 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 1.36e-03 | 18 | 233 | 3 | PS50290 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.38e-03 | 39 | 233 | 4 | PS50055 | |
| Domain | zf-C5HC2 | 1.51e-03 | 5 | 233 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 1.51e-03 | 5 | 233 | 2 | IPR004198 | |
| Domain | FATC | 1.51e-03 | 5 | 233 | 2 | PF02260 | |
| Domain | PTPase_domain | 1.66e-03 | 41 | 233 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 1.66e-03 | 41 | 233 | 4 | PF00102 | |
| Domain | EGF-like_CS | 1.68e-03 | 261 | 233 | 10 | IPR013032 | |
| Domain | EGF_2 | 1.88e-03 | 265 | 233 | 10 | PS01186 | |
| Domain | ARM-like | 2.16e-03 | 270 | 233 | 10 | IPR011989 | |
| Domain | Tyr_Pase_AS | 2.18e-03 | 73 | 233 | 5 | IPR016130 | |
| Domain | FAD_binding_1 | 2.25e-03 | 6 | 233 | 2 | PF00667 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 3.27e-08 | 9 | 174 | 5 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 6.48e-08 | 10 | 174 | 5 | M477 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 6.48e-08 | 10 | 174 | 5 | MM1401 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.22e-06 | 29 | 174 | 6 | M27309 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 6.45e-06 | 38 | 174 | 6 | M39854 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.47e-05 | 65 | 174 | 7 | MM14911 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.77e-05 | 92 | 174 | 8 | M27201 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | NFASC PTPRC PIK3CD CLTC VASP ROCK2 ENAH ROCK1 EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 2.15e-05 | 261 | 174 | 13 | MM15676 |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 3.54e-05 | 31 | 174 | 5 | M39369 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 3.69e-05 | 51 | 174 | 6 | M27311 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | MAP3K3 PIK3CD MAP3K11 MAP4K2 MAP4K3 PRKAG3 MAP4K5 MAP4K1 MAPK6 | 3.74e-05 | 132 | 174 | 9 | M39338 |
| Pathway | BIOCARTA_MAPK_PATHWAY | 4.13e-05 | 76 | 174 | 7 | MM1433 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 5.63e-05 | 34 | 174 | 5 | MM15025 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 5.99e-05 | 18 | 174 | 4 | MM15023 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 6.24e-05 | 81 | 174 | 7 | M13863 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 1.78e-04 | 43 | 174 | 5 | M238 | |
| Pathway | WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS | 1.96e-04 | 24 | 174 | 4 | M39850 | |
| Pathway | WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19 | 4.18e-04 | 29 | 174 | 4 | M40051 | |
| Pubmed | 8.77e-11 | 6 | 239 | 5 | 20457185 | ||
| Pubmed | 2.17e-09 | 4 | 239 | 4 | 25865415 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 KDM5C STK10 CACTIN PTPRC SSH1 ANAPC1 CLTC CPSF1 MN1 VCPIP1 ROCK2 EP400 YTHDC2 RFX7 ZFX PPP1R2 NCOR2 MYOF CSNK1E MAP4K1 PRKDC ATM | 5.09e-09 | 774 | 239 | 23 | 15302935 |
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 6.57e-09 | 11 | 239 | 5 | 9924185 | |
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 6.57e-09 | 11 | 239 | 5 | 38894703 | |
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 1.08e-08 | 5 | 239 | 4 | 30104684 | |
| Pubmed | 1.81e-08 | 13 | 239 | 5 | 22569571 | ||
| Pubmed | 1.81e-08 | 13 | 239 | 5 | 22640814 | ||
| Pubmed | 2.80e-08 | 14 | 239 | 5 | 22768092 | ||
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 3.23e-08 | 6 | 239 | 4 | 15033447 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 INTS1 IRAK1 ZZEF1 SH3BP4 STK10 SARS2 CLCN7 SSH1 PIK3CD CPSF1 MAP3K11 JOSD1 KAZALD1 CAMSAP1 EP400 SZT2 UBE3B LARS2 ANO8 ORC1 NCOR2 MYOF OGDHL PRKDC MAPKBP1 | 5.59e-08 | 1105 | 239 | 26 | 35748872 |
| Pubmed | MRPS27 TMEM200A NLGN3 ZNF836 FAT2 SSH1 SACS ADAMTS16 DOCK2 ROCK2 NTNG1 CILK1 RNF213 ANO8 MYOF UTP4 UNC80 | 6.80e-08 | 493 | 239 | 17 | 15368895 | |
| Pubmed | 7.49e-08 | 7 | 239 | 4 | 7560270 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 7.49e-08 | 7 | 239 | 4 | 20843900 | |
| Pubmed | 7.49e-08 | 7 | 239 | 4 | 35228700 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ERCC3 RRP1B INTS1 IRAK1 RCC2 ITK MAP3K3 PHKA1 STK10 ANAPC1 MAP3K11 STK24 MAP4K3 HIPK2 PPP1R2 NCOR2 MYOF CSNK1E MAP4K5 MAP4K1 MAPK6 EPHA4 EPHA7 | 9.72e-08 | 910 | 239 | 23 | 36736316 |
| Pubmed | 1.17e-07 | 18 | 239 | 5 | 19078961 | ||
| Pubmed | 1.49e-07 | 8 | 239 | 4 | 8175718 | ||
| Pubmed | Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. | 1.49e-07 | 8 | 239 | 4 | 18185516 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | CCT3 VCPIP1 ROCK2 DNHD1 RARS1 SZT2 RNF213 CHD9 YTHDC2 ORC1 OTOG | 2.36e-07 | 208 | 239 | 11 | 33230847 |
| Pubmed | 2.73e-07 | 21 | 239 | 5 | 25708312 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 16835366 | ||
| Pubmed | Identification of a mouse male-specific transplantation antigen, H-Y. | 3.20e-07 | 3 | 239 | 3 | 7544442 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 15017002 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 15304513 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 1356407 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | ITK PTPN2 PTPRD PCDH15 MN1 STK24 NTNG1 CILK1 TG UNC13C CACNA2D3 EPHA8 | 3.54e-07 | 265 | 239 | 12 | 19240061 |
| Pubmed | 4.42e-07 | 10 | 239 | 4 | 25073978 | ||
| Pubmed | Mapping of the phosphorylase kinase alpha subunit gene on the mouse X chromosome. | 4.42e-07 | 10 | 239 | 4 | 1973380 | |
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 4.42e-07 | 10 | 239 | 4 | 16547242 | |
| Pubmed | 4.42e-07 | 10 | 239 | 4 | 36733270 | ||
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 4.42e-07 | 10 | 239 | 4 | 21789198 | |
| Pubmed | 6.91e-07 | 11 | 239 | 4 | 7683413 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CCT3 INTS1 NFASC ZZEF1 TTLL12 CDH20 AGTR2 CLTC CPSF1 MROH9 DNAH3 RARS1 LYG2 ICA1 RNF213 RCAN3 PRKDC ATM SLC26A11 | 9.70e-07 | 736 | 239 | 19 | 29676528 |
| Pubmed | 1.16e-06 | 78 | 239 | 7 | 17192257 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 12832488 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 26518133 | ||
| Pubmed | Neuronal nitric oxide synthase is necessary for elimination of Giardia lamblia infections in mice. | 1.28e-06 | 4 | 239 | 3 | 16365445 | |
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 1.28e-06 | 4 | 239 | 3 | 18821008 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 25080596 | ||
| Pubmed | Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. | 1.28e-06 | 4 | 239 | 3 | 20692323 | |
| Pubmed | 1.48e-06 | 13 | 239 | 4 | 22724066 | ||
| Pubmed | Alternative splice variants encoding unstable protein domains exist in the human brain. | 1.48e-06 | 13 | 239 | 4 | 15491607 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PTPN22 KDM5D SH3BP4 STK10 AEBP1 CLTC CAMSAP1 VASP FOXI1 EP400 NCOR2 MAP4K5 MAP4K1 ATM | 1.96e-06 | 430 | 239 | 14 | 35044719 |
| Pubmed | 2.06e-06 | 14 | 239 | 4 | 26941654 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | PSKH1 KLHL32 ITK BMX MAP4K2 SPSB3 CILK1 CSNK1E MAP4K1 PSKH2 EPHA4 KLHL26 EPHB1 | 2.12e-06 | 372 | 239 | 13 | 22939624 |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 2.80e-06 | 15 | 239 | 4 | 14762062 | |
| Pubmed | 2.97e-06 | 58 | 239 | 6 | 11140838 | ||
| Pubmed | RRP1B TEX2 MRPS27 LACTB SH3BP4 TTLL12 PTPN2 CACTIN SARS2 CLCN7 SACS GLG1 CLTC DNAJC24 SDHB TNPO1 RTN4IP1 HEATR1 AAR2 MRPL39 CSNK1E MAP4K5 UTP4 ATM PACSIN2 AQR EPHA7 | 4.61e-06 | 1487 | 239 | 27 | 33957083 | |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 4.82e-06 | 17 | 239 | 4 | 12217323 | |
| Pubmed | 6.17e-06 | 18 | 239 | 4 | 18985723 | ||
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 6.17e-06 | 18 | 239 | 4 | 12023983 | |
| Pubmed | ERCC3 CCT3 RRP1B RCC2 SH3BP4 CLTC CPSF1 VASP SDHB TNPO1 ROCK2 RARS1 CHD9 RFX7 SYT7 PPP1R2 NCOR2 MYOF CSNK1E UTP4 DDX3Y PRKDC PCID2 AQR | 6.19e-06 | 1247 | 239 | 24 | 27684187 | |
| Pubmed | 6.31e-06 | 6 | 239 | 3 | 21751815 | ||
| Pubmed | 6.38e-06 | 141 | 239 | 8 | 20056178 | ||
| Pubmed | SLC43A2 TEX2 KLHL32 MAP3K3 NLGN3 PTPRC PIK3CD GLG1 CLTC N4BP2L2 STK24 TNPO1 MAP4K3 ICA1 HIPK2 RTN4IP1 HEATR1 CSNK1E OGDHL DDX3Y ROCK1 PACSIN2 | 6.76e-06 | 1084 | 239 | 22 | 11544199 | |
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 7.77e-06 | 19 | 239 | 4 | 12684176 | |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 9.66e-06 | 20 | 239 | 4 | 11256076 | |
| Pubmed | 9.66e-06 | 20 | 239 | 4 | 10207129 | ||
| Pubmed | 9.66e-06 | 20 | 239 | 4 | 9530499 | ||
| Pubmed | 9.66e-06 | 20 | 239 | 4 | 9576626 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 16080114 | ||
| Pubmed | EphB regulates L1 phosphorylation during retinocollicular mapping. | 1.10e-05 | 7 | 239 | 3 | 22579729 | |
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 17021187 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 16101898 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 9736773 | ||
| Pubmed | 1.19e-05 | 21 | 239 | 4 | 9267020 | ||
| Pubmed | 1.19e-05 | 21 | 239 | 4 | 11128993 | ||
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 1.19e-05 | 21 | 239 | 4 | 10730216 | |
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 1.19e-05 | 21 | 239 | 4 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 1.19e-05 | 21 | 239 | 4 | 20112066 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CCT3 INTS1 ANAPC1 CPSF1 STK24 VASP TNPO1 DOCK2 ROCK2 YTHDC2 NCOR2 ENAH PRKDC ATM AQR | 1.41e-05 | 582 | 239 | 15 | 20467437 |
| Pubmed | 1.44e-05 | 22 | 239 | 4 | 22305495 | ||
| Pubmed | 1.44e-05 | 22 | 239 | 4 | 38736483 | ||
| Pubmed | MON2 TEX2 MRPS27 LRP1B CDKL5 PTPN2 GLG1 CLTC PPP1R2P1 CAMSAP1 NOS1 SDHB VCPIP1 RARS1 NRCAM ANO8 PPP1R2 CSNK1E ENAH GABRA1 GABRA2 GABRA5 | 1.45e-05 | 1139 | 239 | 22 | 36417873 | |
| Pubmed | MON2 TEX2 TTC4 ANAPC1 C1D CAMSAP1 VCPIP1 EP400 ICA1 RNF213 RCAN3 PPP1R2 POLR3B CSNK1E TMEM30A ROCK1 PACSIN2 | 1.48e-05 | 733 | 239 | 17 | 34672954 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CCT3 RRP1B TEX2 ACTBL2 MRPS27 ZZEF1 TTC4 LACTB PTPN2 SARS2 CLTC CPSF1 SPRYD4 SDHB VCPIP1 MRPL54 RNF213 YTHDC2 RTN4IP1 HEATR1 LARS2 MRPL39 CSNK1E UTP4 OGDHL ALDH4A1 | 1.50e-05 | 1496 | 239 | 26 | 32877691 |
| Pubmed | Expression of mouse Foxi class genes in early craniofacial development. | 1.75e-05 | 8 | 239 | 3 | 15376323 | |
| Pubmed | High-density molecular map of the central span of the mouse X chromosome. | 1.75e-05 | 8 | 239 | 3 | 1675191 | |
| Pubmed | Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. | 1.75e-05 | 8 | 239 | 3 | 2034279 | |
| Pubmed | 1.75e-05 | 8 | 239 | 3 | 11528422 | ||
| Pubmed | 1.90e-05 | 214 | 239 | 9 | 22199357 | ||
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 2.07e-05 | 24 | 239 | 4 | 16446123 | |
| Pubmed | 2.40e-05 | 83 | 239 | 6 | 11114734 | ||
| Pubmed | 2.61e-05 | 9 | 239 | 3 | 11403717 | ||
| Pubmed | Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. | 2.61e-05 | 9 | 239 | 3 | 7874112 | |
| Pubmed | NCOA3 ERCC3 CCT3 KDM5C INTS1 GBE1 PTPN2 CACTIN ANAPC1 CPSF1 TNPO1 EP400 RNF213 CHD9 RNF126 NCOR2 POLR3B PRKDC ATM AQR | 2.69e-05 | 1014 | 239 | 20 | 32416067 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SCN11A CCT3 ACTBL2 GBE1 NEB SH3BP4 SLC22A8 GLG1 CLTC N4BP2L2 STK24 VASP DNHD1 RARS1 ANPEP UBL3 RBP4 MYOF SLC26A11 PACSIN2 | 2.77e-05 | 1016 | 239 | 20 | 19056867 |
| Pubmed | 3.71e-05 | 10 | 239 | 3 | 28197551 | ||
| Pubmed | Enhancer activation requires trans-recruitment of a mega transcription factor complex. | 3.71e-05 | 10 | 239 | 3 | 25303530 | |
| Pubmed | 3.71e-05 | 10 | 239 | 3 | 2055107 | ||
| Pubmed | MON2 CCT3 RRP1B ACTBL2 PTPN22 PHKA1 PTPN2 CACTIN PTPRC PTPRD CLCN7 SSH1 CLTC CPSF1 RNF213 RCAN3 PPP1R2 NCOR2 ENAH ROCK1 | 4.32e-05 | 1049 | 239 | 20 | 27880917 | |
| Pubmed | 4.70e-05 | 2 | 239 | 2 | 36470472 | ||
| Pubmed | 4.70e-05 | 2 | 239 | 2 | 11378843 | ||
| Pubmed | 4.70e-05 | 2 | 239 | 2 | 15926917 | ||
| Pubmed | 4.70e-05 | 2 | 239 | 2 | 22378773 | ||
| Pubmed | 4.70e-05 | 2 | 239 | 2 | 12570871 | ||
| Pubmed | 4.70e-05 | 2 | 239 | 2 | 22763624 | ||
| Pubmed | ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape. | 4.70e-05 | 2 | 239 | 2 | 22462535 | |
| Pubmed | Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer. | 4.70e-05 | 2 | 239 | 2 | 22038115 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 2.45e-08 | 5 | 153 | 4 | 655 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 7.65e-08 | 14 | 153 | 5 | 1095 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 4.29e-07 | 19 | 153 | 5 | 563 | |
| GeneFamily | Fibronectin type III domain containing | NFASC PTPRC PTPRD LRFN5 NRCAM EPHA10 EPHA4 EPHA7 EPHA8 EPHB1 | 1.08e-06 | 160 | 153 | 10 | 555 |
| GeneFamily | Forkhead boxes | 1.57e-06 | 43 | 153 | 6 | 508 | |
| GeneFamily | ENAH/VASPs | 2.12e-04 | 3 | 153 | 2 | 946 | |
| GeneFamily | Sterile alpha motif domain containing | 9.05e-04 | 88 | 153 | 5 | 760 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.19e-03 | 25 | 153 | 3 | 775 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.88e-03 | 206 | 153 | 7 | 682 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.50e-03 | 161 | 153 | 6 | 593 | |
| GeneFamily | Maestro heat like repeat containing | 3.72e-03 | 11 | 153 | 2 | 636 | |
| GeneFamily | Mitochondrial ribosomal proteins | 4.53e-03 | 79 | 153 | 4 | 646 | |
| Coexpression | HOLLMANN_APOPTOSIS_VIA_CD40_UP | PTPN22 KDM5D PTPRC SDHB IRF8 RNF126 RGS13 NCOR2 MAP4K1 DDX3Y ALDH4A1 MAPK6 | 3.97e-07 | 203 | 239 | 12 | M9695 |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP | HUNK ITK MAP3K3 SACS SETD3 ROCK2 DNAH3 YTHDC2 DDX3Y MAPKBP1 EPHA7 | 2.13e-06 | 197 | 239 | 11 | M7682 |
| Coexpression | FIRESTEIN_PROLIFERATION | 3.16e-06 | 166 | 239 | 10 | M5354 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | NCOA3 CWF19L2 ERCC3 KDM5C PTPN22 RCC2 ITK STK10 PTPN2 MINDY3 PTPRC PIK3CD CLTC MAP3K11 SERTAD1 GLIPR1 TNPO1 UBL3 UBE3B IRF8 RTN4IP1 POLR3B MAP4K1 MPLKIP TMEM30A ATM MAPK6 SLC26A11 PSD4 | 3.38e-06 | 1239 | 239 | 29 | M1743 |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | NCOA3 CWF19L2 ERCC3 KDM5C PTPN22 RCC2 ITK STK10 PTPN2 MINDY3 PTPRC PIK3CD CLTC MAP3K11 SERTAD1 GLIPR1 TNPO1 UBL3 UBE3B IRF8 RTN4IP1 POLR3B MAP4K1 MPLKIP TMEM30A ATM MAPK6 SLC26A11 PSD4 | 6.05e-06 | 1277 | 239 | 29 | MM1032 |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | PTPN22 ELMO1 ITK STK10 PTPRC GVINP1 PIK3CD CD302 PLCB2 GLIPR1 DOCK2 IRF8 LAMA2 MAP4K1 PPP1R16B EPHA4 | 1.10e-05 | 485 | 239 | 16 | M8513 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 GBE1 ZZEF1 STK10 PTPN2 SACS N4BP2L2 SETD3 MN1 STK24 ROCK2 UBL3 CHD9 LARS2 NCOR2 MYOF MAP4K5 SERPINE1 ROCK1 MAPK6 AQR EPHA4 | 1.35e-05 | 856 | 239 | 22 | M4500 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | KDM5C TRPC6 STARD9 LRFN5 ANPEP SLC19A2 NTNG1 ADAMTS8 MAP4K5 CACNA2D3 GABRA1 GABRA4 EPHA7 EPHB1 | 2.77e-05 | 411 | 239 | 14 | M1351 |
| Coexpression | SU_THYMUS | 2.91e-05 | 20 | 239 | 4 | M13095 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | KDM5C TRPC6 STARD9 LRFN5 ANPEP SLC19A2 NTNG1 ADAMTS8 MAP4K5 CACNA2D3 GABRA1 GABRA4 EPHA7 EPHB1 | 3.16e-05 | 416 | 239 | 14 | MM1002 |
| Coexpression | RUNNE_GENDER_EFFECT_UP | 6.04e-05 | 9 | 239 | 3 | M17072 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN | 7.73e-05 | 194 | 239 | 9 | M8408 | |
| Coexpression | GSE16266_CTRL_VS_LPS_STIM_MEF_UP | SLC43A2 RCC2 SH3BP4 SSH1 CAMSAP1 SERTAD1 CHD9 NCOR2 SERPINE1 | 9.04e-05 | 198 | 239 | 9 | M7219 |
| Coexpression | GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP | 9.39e-05 | 199 | 239 | 9 | M6395 | |
| Coexpression | GSE5960_TH1_VS_ANERGIC_TH1_UP | 9.39e-05 | 199 | 239 | 9 | M5637 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 9.76e-05 | 200 | 239 | 9 | M9439 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP | 9.76e-05 | 200 | 239 | 9 | M5231 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN | 1.06e-04 | 158 | 239 | 8 | M8993 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NEB LRP1B PTPRD ADAMTS16 PCDH15 NRCAM CPS1 HMCN1 UNC13C UNC80 EPHA10 OTOG EPHA7 | 2.25e-11 | 184 | 237 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NEB LRP1B PTPRD ADAMTS16 PCDH15 NRCAM CPS1 HMCN1 UNC13C UNC80 EPHA10 OTOG EPHA7 | 2.25e-11 | 184 | 237 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NEB LRP1B PTPRD ADAMTS16 PCDH15 NRCAM CPS1 HMCN1 UNC13C UNC80 EPHA10 OTOG EPHA7 | 2.25e-11 | 184 | 237 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | RV-17._Lymphocyte|RV / Chamber and Cluster_Paper | TDRD15 TRPM2 PTPN22 ITK NLGN3 PTPRC GLIPR1 DOCK2 TRABD2A RGS13 MAP4K1 | 6.64e-10 | 153 | 237 | 11 | e1ea621184014415870e00d511386b8cc3e0833b |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | TDRD15 TRPM2 PTPN22 ITK NLGN3 PTPRC GLIPR1 DOCK2 TRABD2A RGS13 MAP4K1 | 7.63e-10 | 155 | 237 | 11 | 189276a3b400b2202e6681e23732e6452bfe704e |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTPN22 ELMO1 ITK PTPRC PIK3CD DOCK2 TRABD2A RCAN3 MAP4K1 PPP1R16B ATM | 5.23e-09 | 186 | 237 | 11 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTPN22 ELMO1 ITK PTPRC PIK3CD DOCK2 TRABD2A RCAN3 MAP4K1 PPP1R16B ATM | 5.23e-09 | 186 | 237 | 11 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTPN22 ELMO1 ITK PTPRC PIK3CD DOCK2 TRABD2A RCAN3 MAP4K1 PPP1R16B ATM | 5.23e-09 | 186 | 237 | 11 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | ELMO1 FAP PTPRD LRFN5 PCDH15 LAMA2 NTNG1 ADAMTS8 HMCN1 ENAH UNC13C | 7.68e-09 | 193 | 237 | 11 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTPN22 ELMO1 ITK STK10 PTPRC PIK3CD PLCB2 DOCK2 TRABD2A PPP1R16B ATM | 8.11e-09 | 194 | 237 | 11 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-08 | 153 | 237 | 10 | 3b1b0cc8e9dd2b1484649789330713282ee44414 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ELMO1 ITK STK10 PTPRC PIK3CD DOCK2 TRABD2A RASGRF2 RCAN3 MAP4K1 PPP1R16B | 1.11e-08 | 200 | 237 | 11 | cded40d5069a6fdbd90ac9a2a0bbef11727b28d5 |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ELMO1 ITK STK10 PTPRC PIK3CD DOCK2 TRABD2A RASGRF2 RCAN3 MAP4K1 PPP1R16B | 1.11e-08 | 200 | 237 | 11 | e0cec0a844b7c1f8edee4c005af27766754e470a |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | HUNK LRP1B SH3BP4 ADAMTS16 CWH43 NRCAM MAP4K3 FHOD3 UNC13C GABRA2 | 6.47e-08 | 186 | 237 | 10 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | PTPN22 ITK PTPRC PIK3CD DOCK2 TRABD2A RASGRF2 RCAN3 PPP1R16B ATM | 8.71e-08 | 192 | 237 | 10 | 69a2b04f03a1b82d067018379f7b8a116e954040 |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | PTPN22 ITK STK10 PTPRC PIK3CD DOCK2 RASGRF2 RCAN3 PPP1R16B ATM | 9.60e-08 | 194 | 237 | 10 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ELMO1 FAP LRFN5 PCDH15 LAMA2 NTNG1 ADAMTS8 HMCN1 ENAH UNC13C | 9.60e-08 | 194 | 237 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.01e-07 | 195 | 237 | 10 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.01e-07 | 195 | 237 | 10 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-07 | 197 | 237 | 10 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-07 | 198 | 237 | 10 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-07 | 199 | 237 | 10 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-07 | 199 | 237 | 10 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | PDE3A TRPC6 ADPRH SLC22A8 AEBP1 ANPEP SLC17A4 LAMA2 MYOF SERPINE1 | 1.28e-07 | 200 | 237 | 10 | 8b80811a0ec28d1d763c10b095d1969bccbe82d4 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE3A TRPC6 NFASC ELMO1 AEBP1 LRFN5 LAMA2 NTNG1 ADAMTS8 HMCN1 | 1.28e-07 | 200 | 237 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial-Proteoglycan-expressing_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | PDE3A TRPC6 ADPRH SLC22A8 AEBP1 ANPEP SLC17A4 LAMA2 MYOF SERPINE1 | 1.28e-07 | 200 | 237 | 10 | 52ec80f3922ae6ee3565d5993c2fc56bb3a3199a |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PTPN22 ELMO1 ITK STK10 PTPRC PIK3CD DOCK2 RASGRF2 MAP4K1 PPP1R16B | 1.28e-07 | 200 | 237 | 10 | c6c2b39359c65c9444987d02d1c899dff2ad1366 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TRPC6 NFASC ELMO1 AEBP1 LRFN5 PCDH15 LAMA2 NTNG1 ADAMTS8 HMCN1 | 1.28e-07 | 200 | 237 | 10 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PTPN22 ELMO1 ITK STK10 PTPRC PIK3CD DOCK2 TRABD2A RCAN3 PPP1R16B | 1.28e-07 | 200 | 237 | 10 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE3A NFASC ELMO1 AEBP1 LRFN5 PCDH15 LAMA2 NTNG1 ADAMTS8 HMCN1 | 1.28e-07 | 200 | 237 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-07 | 162 | 237 | 9 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 5.74e-07 | 181 | 237 | 9 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-07 | 183 | 237 | 9 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.59e-07 | 184 | 237 | 9 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | TMEM200A AEBP1 LRFN5 PCDH15 LAMA2 NTNG1 ADAMTS8 HMCN1 SERPINE1 | 7.54e-07 | 187 | 237 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-07 | 187 | 237 | 9 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | NBEAL1 TMEM200A ROCK2 MYOF ENAH SERPINE1 ROCK1 UNC13C PACSIN2 | 8.24e-07 | 189 | 237 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.61e-07 | 190 | 237 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-07 | 191 | 237 | 9 | d9506b88d806aadd4c2b9bf86fe994c47799e7f6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-07 | 191 | 237 | 9 | 9aabbc65430e2233b8f2d3fff9face7807b88b48 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-07 | 191 | 237 | 9 | b42c54308abe1241cc38ddce96b9d38d07983891 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.00e-07 | 191 | 237 | 9 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.40e-07 | 192 | 237 | 9 | 92f141d5ac462f652f405efa73ac6ef751f40ea3 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.81e-07 | 193 | 237 | 9 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 9.81e-07 | 193 | 237 | 9 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.81e-07 | 193 | 237 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | COVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type | 9.81e-07 | 193 | 237 | 9 | 780e23e2705fc5c1b70e37568b79731ced5038bd | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.81e-07 | 193 | 237 | 9 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-06 | 194 | 237 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.02e-06 | 194 | 237 | 9 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 1.02e-06 | 194 | 237 | 9 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.07e-06 | 195 | 237 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 195 | 237 | 9 | 2d485373bfd9bb4bb9236bf0b31d03e132c8018f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.07e-06 | 195 | 237 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-06 | 196 | 237 | 9 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 196 | 237 | 9 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 196 | 237 | 9 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 197 | 237 | 9 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.16e-06 | 197 | 237 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.21e-06 | 198 | 237 | 9 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_only / Treatment groups by lineage, cell group, cell type | 1.21e-06 | 198 | 237 | 9 | d205dfcfe1f20e1e21bf84759e723d9e6e610a5c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.21e-06 | 198 | 237 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.21e-06 | 198 | 237 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-06 | 199 | 237 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 199 | 237 | 9 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 199 | 237 | 9 | bc93e5c36ab60b66fb633c954b05d4dc09a7f152 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 199 | 237 | 9 | 6150b272313d3fbf5ddcb3a8d51862d368220fe2 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 199 | 237 | 9 | b947ecaf912d97869f6df32736b8c2b2dd695d66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 148 | 237 | 8 | 12fa2c4922f03803006c606b1b16e79441e3bb13 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-06 | 200 | 237 | 9 | d8459e45a8396a9ee063666a1928c649162c5727 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PTPN22 TMEM200A ITK STK10 PTPRC PIK3CD DOCK2 RASGRF2 PPP1R16B | 1.32e-06 | 200 | 237 | 9 | be9a43acc2f926b9433ab3f018b911b03896a924 |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PTPN22 TMEM200A ITK STK10 PTPRC DOCK2 RASGRF2 PPP1R2 PPP1R16B | 1.32e-06 | 200 | 237 | 9 | 20ffb3436d08042f77800513e6ddb3bbc38ae6fe |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-06 | 200 | 237 | 9 | 9ef322486e46e4ff05a8cbe06cf8019e996c94b3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 157 | 237 | 8 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-06 | 162 | 237 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.71e-06 | 163 | 237 | 8 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-mature_NK_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-06 | 166 | 237 | 8 | 410843ad44f9b22d5476119ac0d7c9168e17ac4b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.55e-06 | 169 | 237 | 8 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-06 | 171 | 237 | 8 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-06 | 171 | 237 | 8 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-06 | 172 | 237 | 8 | 7af0713c40ea48f1e92c859c4fc4d8f0137c4415 | |
| ToppCell | normal-na-Hematopoietic-Progen-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.22e-06 | 173 | 237 | 8 | e666364eb110c1c976e5b09a632dd1454513f131 | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 4.22e-06 | 173 | 237 | 8 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.22e-06 | 173 | 237 | 8 | 79d11f94a8f6a420c18c2fef0da77e9af3204765 | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 5.20e-06 | 178 | 237 | 8 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.88e-06 | 181 | 237 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 5.88e-06 | 181 | 237 | 8 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.88e-06 | 181 | 237 | 8 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-06 | 182 | 237 | 8 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.38e-06 | 183 | 237 | 8 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-06 | 184 | 237 | 8 | 6ce9aea2c1c9098f37bdf5135b5e2192ef03b50b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-06 | 184 | 237 | 8 | 895f7492d47c4782809bbb125c258127de04f888 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 6.91e-06 | 185 | 237 | 8 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-06 | 186 | 237 | 8 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 187 | 237 | 8 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 7.47e-06 | 187 | 237 | 8 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.47e-06 | 187 | 237 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-06 | 188 | 237 | 8 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-06 | 189 | 237 | 8 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.07e-06 | 189 | 237 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| Drug | Meprobamate | 6.82e-10 | 6 | 236 | 5 | DB00371 | |
| Drug | Flumazenil | 1.13e-08 | 4 | 236 | 4 | DB01205 | |
| Drug | Ethchlorvynol | 1.40e-08 | 9 | 236 | 5 | DB00189 | |
| Drug | Secobarbital | 2.77e-08 | 10 | 236 | 5 | DB00418 | |
| Drug | Chlordiazepoxide | 2.77e-08 | 10 | 236 | 5 | DB00475 | |
| Drug | Metharbital | 2.77e-08 | 10 | 236 | 5 | DB00463 | |
| Drug | Pentobarbital | 2.77e-08 | 10 | 236 | 5 | DB00312 | |
| Drug | Talbutal | 2.77e-08 | 10 | 236 | 5 | DB00306 | |
| Drug | Clobazam | 2.77e-08 | 10 | 236 | 5 | DB00349 | |
| Drug | Butalbital | 2.77e-08 | 10 | 236 | 5 | DB00241 | |
| Drug | Butabarbital | 2.77e-08 | 10 | 236 | 5 | DB00237 | |
| Drug | Bromazepam | 2.77e-08 | 10 | 236 | 5 | DB01558 | |
| Drug | Barbituric acid derivative | 2.77e-08 | 10 | 236 | 5 | DB01496 | |
| Drug | Barbital | 2.77e-08 | 10 | 236 | 5 | DB01483 | |
| Drug | Hexobarbital | 2.77e-08 | 10 | 236 | 5 | DB01355 | |
| Drug | Aprobarbital | 2.77e-08 | 10 | 236 | 5 | DB01352 | |
| Drug | Amobarbital | 2.77e-08 | 10 | 236 | 5 | DB01351 | |
| Drug | Heptabarbital | 2.77e-08 | 10 | 236 | 5 | DB01354 | |
| Drug | Butethal | 2.77e-08 | 10 | 236 | 5 | DB01353 | |
| Drug | Methylphenobarbital | 2.77e-08 | 10 | 236 | 5 | DB00849 | |
| Drug | Oxazepam | 2.77e-08 | 10 | 236 | 5 | DB00842 | |
| Drug | Primidone | 2.77e-08 | 10 | 236 | 5 | DB00794 | |
| Drug | Midazolam | 2.77e-08 | 10 | 236 | 5 | DB00683 | |
| Drug | Flurazepam | 2.77e-08 | 10 | 236 | 5 | DB00690 | |
| Drug | Clonazepam | 2.77e-08 | 10 | 236 | 5 | DB01068 | |
| Drug | Thiopental | 5.04e-08 | 11 | 236 | 5 | DB00599 | |
| Drug | Alprazolam | 5.04e-08 | 11 | 236 | 5 | DB00404 | |
| Drug | Temazepam | 5.04e-08 | 11 | 236 | 5 | DB00231 | |
| Drug | Nitrazepam | 5.04e-08 | 11 | 236 | 5 | DB01595 | |
| Drug | Lorazepam | 5.04e-08 | 11 | 236 | 5 | DB00186 | |
| Drug | Phenobarbital | 5.04e-08 | 11 | 236 | 5 | DB01174 | |
| Drug | Triazolam | 5.04e-08 | 11 | 236 | 5 | DB00897 | |
| Drug | Clorazepate | 5.04e-08 | 11 | 236 | 5 | DB00628 | |
| Drug | Eszopiclone | 5.58e-08 | 5 | 236 | 4 | DB00402 | |
| Drug | Zopiclone | 5.58e-08 | 5 | 236 | 4 | DB01198 | |
| Drug | Lorazepam | 5.58e-08 | 5 | 236 | 4 | ctd:D008140 | |
| Drug | Flunitrazepam | 1.66e-07 | 6 | 236 | 4 | DB01544 | |
| Drug | Quazepam | 3.84e-07 | 7 | 236 | 4 | DB01589 | |
| Drug | dihydroxyaflavinine | 6.41e-07 | 17 | 236 | 5 | CID000156857 | |
| Drug | Adinazolam | 7.63e-07 | 8 | 236 | 4 | DB00546 | |
| Drug | Fludiazepam | 7.63e-07 | 8 | 236 | 4 | DB01567 | |
| Drug | Clotiazepam | 7.63e-07 | 8 | 236 | 4 | DB01559 | |
| Drug | Cinolazepam | 7.63e-07 | 8 | 236 | 4 | DB01594 | |
| Drug | Prazepam | 7.63e-07 | 8 | 236 | 4 | DB01588 | |
| Drug | Estazolam | 7.63e-07 | 8 | 236 | 4 | DB01215 | |
| Drug | Halazepam | 7.63e-07 | 8 | 236 | 4 | DB00801 | |
| Drug | Zolpidem | 1.10e-06 | 3 | 236 | 3 | DB00425 | |
| Drug | etifoxine | 1.18e-06 | 19 | 236 | 5 | CID000030768 | |
| Drug | AC1Q5S0Y | 1.28e-06 | 103 | 236 | 9 | CID000005650 | |
| Drug | Diazepam | 1.36e-06 | 9 | 236 | 4 | DB00829 | |
| Drug | tiotidine | 1.36e-06 | 9 | 236 | 4 | ctd:C023990 | |
| Drug | AC1L1FKW | 2.25e-06 | 10 | 236 | 4 | CID000003281 | |
| Drug | fosazepam | 3.51e-06 | 11 | 236 | 4 | CID000037114 | |
| Drug | C19H18ClN3O | 3.51e-06 | 11 | 236 | 4 | CID000027452 | |
| Drug | flutoprazepam | 3.51e-06 | 11 | 236 | 4 | CID000003400 | |
| Drug | Arfendazam | 3.51e-06 | 11 | 236 | 4 | CID000065803 | |
| Drug | camazepam | 3.51e-06 | 11 | 236 | 4 | CID000037367 | |
| Drug | Bu-1014 | 3.51e-06 | 11 | 236 | 4 | CID015942721 | |
| Drug | Zapizolam | 3.51e-06 | 11 | 236 | 4 | CID000068832 | |
| Drug | Reclazepam | 3.51e-06 | 11 | 236 | 4 | CID003052777 | |
| Drug | iclazepam | 3.51e-06 | 11 | 236 | 4 | CID000068777 | |
| Drug | menitrazepam | 3.51e-06 | 11 | 236 | 4 | CID000189875 | |
| Drug | Serin hydrazid | 3.51e-06 | 11 | 236 | 4 | CID000041637 | |
| Drug | sulazepam | 3.51e-06 | 11 | 236 | 4 | CID000017931 | |
| Drug | elfazepam | 3.51e-06 | 11 | 236 | 4 | CID000065445 | |
| Drug | triflubazam | 3.51e-06 | 11 | 236 | 4 | CID000031157 | |
| Drug | uldazepam | 3.51e-06 | 11 | 236 | 4 | CID000034274 | |
| Drug | gidazepam | 3.51e-06 | 11 | 236 | 4 | CID000121919 | |
| Drug | fletazepam | 3.51e-06 | 11 | 236 | 4 | CID000036834 | |
| Drug | methohexital | 4.15e-06 | 24 | 236 | 5 | CID000009034 | |
| Drug | etizolam | 4.37e-06 | 4 | 236 | 3 | ctd:C044610 | |
| Drug | SB-205384 | 5.22e-06 | 12 | 236 | 4 | CID000197690 | |
| Drug | U-93631 | 5.22e-06 | 12 | 236 | 4 | CID000197626 | |
| Drug | haloxazolam | 5.22e-06 | 12 | 236 | 4 | CID000003563 | |
| Drug | doxefazepam | 5.22e-06 | 12 | 236 | 4 | CID000038668 | |
| Drug | pivoxazepam | 5.22e-06 | 12 | 236 | 4 | CID000068722 | |
| Drug | razobazam | 5.22e-06 | 12 | 236 | 4 | CID000071228 | |
| Drug | trans-4-aminocrotonic acid | 6.03e-06 | 67 | 236 | 7 | CID000002766 | |
| Drug | haloperidol; Up 200; 10uM; PC3; HT_HG-U133A | 6.76e-06 | 196 | 236 | 11 | 4468_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; HL60; HG-U133A | KDM5C CACTIN DNAJC24 NOS1 TNPO1 RNF126 ORC1 CSNK1E PPP1R16B ATM MAPKBP1 | 7.44e-06 | 198 | 236 | 11 | 1553_DN |
| Drug | nerisopam | 7.48e-06 | 13 | 236 | 4 | CID000065875 | |
| Drug | flutazolam | 7.48e-06 | 13 | 236 | 4 | CID000003398 | |
| Drug | 4-PIOL | 7.48e-06 | 13 | 236 | 4 | CID000125520 | |
| Drug | AC1MVFYM | 7.48e-06 | 13 | 236 | 4 | CID003707225 | |
| Drug | Ro 11-3128 | 7.48e-06 | 13 | 236 | 4 | CID000093364 | |
| Drug | cinolazepam | 7.48e-06 | 13 | 236 | 4 | CID003033621 | |
| Drug | alpha IMGBL | 7.48e-06 | 13 | 236 | 4 | CID000131516 | |
| Drug | metaclazepam | 7.48e-06 | 13 | 236 | 4 | CID000071272 | |
| Drug | beta-CCt | 1.04e-05 | 14 | 236 | 4 | CID000124514 | |
| Drug | Me-lex | 1.04e-05 | 14 | 236 | 4 | CID000004177 | |
| Drug | ethyl loflazepate | 1.04e-05 | 14 | 236 | 4 | CID000003299 | |
| Drug | clotiazepam | 1.11e-05 | 29 | 236 | 5 | CID000002811 | |
| Drug | allylglycine | 1.32e-05 | 30 | 236 | 5 | CID000014044 | |
| Drug | 3-isothujone | 1.32e-05 | 30 | 236 | 5 | CID000011027 | |
| Drug | SR 95103 | 1.40e-05 | 15 | 236 | 4 | CID000125958 | |
| Drug | pinazepam | 1.40e-05 | 15 | 236 | 4 | CID000040391 | |
| Drug | fludiazepam | 1.40e-05 | 15 | 236 | 4 | CID000003369 | |
| Drug | TBOB | 1.40e-05 | 15 | 236 | 4 | CID000114986 | |
| Drug | loprazolam | 1.40e-05 | 15 | 236 | 4 | CID003033860 | |
| Drug | premazepam | 1.40e-05 | 15 | 236 | 4 | CID000072104 | |
| Disease | Metastatic melanoma | 1.13e-08 | 54 | 236 | 8 | C0278883 | |
| Disease | alcohol use disorder (implicated_via_orthology) | KDM5C KDM5D SSH1 PIK3CD MAP4K2 MAP4K3 MAP4K5 MAP4K1 UNC13C PSD4 | 4.22e-06 | 195 | 236 | 10 | DOID:1574 (implicated_via_orthology) |
| Disease | Rett Syndrome, Atypical | 4.99e-06 | 5 | 236 | 3 | C2748910 | |
| Disease | glycine measurement | 1.53e-05 | 137 | 236 | 8 | EFO_0009767 | |
| Disease | Gastric Adenocarcinoma | 2.95e-05 | 45 | 236 | 5 | C0278701 | |
| Disease | Autistic Disorder | KDM5C NLGN3 NOS2 NRCAM SERPINE1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 5.23e-05 | 261 | 236 | 10 | C0004352 |
| Disease | glutamine measurement, amino acid measurement | 7.95e-05 | 11 | 236 | 3 | EFO_0005134, EFO_0009768 | |
| Disease | Global developmental delay | 1.01e-04 | 133 | 236 | 7 | C0557874 | |
| Disease | chronic hepatitis C virus infection | 1.36e-04 | 33 | 236 | 4 | EFO_0004220 | |
| Disease | rheumatoid arthritis, celiac disease | 1.36e-04 | 33 | 236 | 4 | EFO_0000685, EFO_0001060 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 1.36e-04 | 13 | 236 | 3 | C0751197 | |
| Disease | Hepatic Stupor | 1.36e-04 | 13 | 236 | 3 | C0751198 | |
| Disease | Hepatic Encephalopathy | 1.36e-04 | 13 | 236 | 3 | C0019151 | |
| Disease | Hepatic Coma | 1.36e-04 | 13 | 236 | 3 | C0019147 | |
| Disease | Vitiligo | 1.65e-04 | 101 | 236 | 6 | EFO_0004208 | |
| Disease | familial hypercholesterolemia (is_marker_for) | 1.90e-04 | 3 | 236 | 2 | DOID:13810 (is_marker_for) | |
| Disease | non-word reading | 2.02e-04 | 67 | 236 | 5 | EFO_0005299 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 2.14e-04 | 15 | 236 | 3 | DOID:13413 (biomarker_via_orthology) | |
| Disease | threonine measurement | 2.14e-04 | 37 | 236 | 4 | EFO_0009775 | |
| Disease | Developmental delay (disorder) | 2.14e-04 | 37 | 236 | 4 | C0424605 | |
| Disease | ciliopathy (implicated_via_orthology) | 2.91e-04 | 40 | 236 | 4 | DOID:0060340 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.55e-04 | 163 | 236 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | autoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease | 3.77e-04 | 18 | 236 | 3 | EFO_0003779, EFO_0004237, EFO_0006812 | |
| Disease | urinary sodium to creatinine ratio | 3.78e-04 | 4 | 236 | 2 | EFO_0009883 | |
| Disease | Photosensitive Trichothiodystrophy | 3.78e-04 | 4 | 236 | 2 | C1866504 | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 3.78e-04 | 4 | 236 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | multiple sclerosis symptom measurement | 5.00e-04 | 46 | 236 | 4 | EFO_0803536 | |
| Disease | Infiltrating duct carcinoma of female breast | 6.04e-04 | 21 | 236 | 3 | C3165106 | |
| Disease | prothrombin time measurement | 6.04e-04 | 21 | 236 | 3 | EFO_0008390 | |
| Disease | gestational age, birth measurement | 6.04e-04 | 21 | 236 | 3 | EFO_0005112, EFO_0006921 | |
| Disease | Anoxic-Ischemic Encephalopathy | 6.27e-04 | 5 | 236 | 2 | C0752305 | |
| Disease | Hypoxic-Ischemic Encephalopathy | 6.27e-04 | 5 | 236 | 2 | C0752304 | |
| Disease | Anoxia-Ischemia, Cerebral | 6.27e-04 | 5 | 236 | 2 | C0752307 | |
| Disease | Anoxia-Ischemia, Brain | 6.27e-04 | 5 | 236 | 2 | C0752306 | |
| Disease | Hypoxia-Ischemia, Brain | 6.27e-04 | 5 | 236 | 2 | C0752308 | |
| Disease | arecaidine measurement | 6.27e-04 | 5 | 236 | 2 | EFO_0801112 | |
| Disease | Cerebral Hypoxia-Ischemia | 6.27e-04 | 5 | 236 | 2 | C0178540 | |
| Disease | obsolete Mendelian syndromes with cleft lip/palate | 7.95e-04 | 23 | 236 | 3 | MONDO_0015335 | |
| Disease | Ureteral obstruction | 9.03e-04 | 24 | 236 | 3 | C0041956 | |
| Disease | extraversion | 9.35e-04 | 6 | 236 | 2 | EFO_0004317 | |
| Disease | Trichothiodystrophy Syndromes | 9.35e-04 | 6 | 236 | 2 | C1955934 | |
| Disease | axial length measurement, refractive error | 9.35e-04 | 6 | 236 | 2 | EFO_0005318, MONDO_0004892 | |
| Disease | Ataxia | 1.02e-03 | 25 | 236 | 3 | C0004134 | |
| Disease | isoleucine measurement | 1.06e-03 | 56 | 236 | 4 | EFO_0009793 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.22e-03 | 147 | 236 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | glucose tolerance test | 1.28e-03 | 27 | 236 | 3 | EFO_0004307 | |
| Disease | functional impairment measurement | 1.30e-03 | 7 | 236 | 2 | EFO_0005412 | |
| Disease | Juvenile pauciarticular chronic arthritis | 1.30e-03 | 7 | 236 | 2 | C2931171 | |
| Disease | Irido-corneo-trabecular dysgenesis (disorder) | 1.30e-03 | 7 | 236 | 2 | C0344559 | |
| Disease | fructosamine measurement | 1.30e-03 | 7 | 236 | 2 | EFO_0009303 | |
| Disease | MASA syndrome (implicated_via_orthology) | 1.30e-03 | 7 | 236 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Generalized seizures | 1.33e-03 | 101 | 236 | 5 | C0234533 | |
| Disease | Clonic Seizures | 1.33e-03 | 101 | 236 | 5 | C0234535 | |
| Disease | Non-epileptic convulsion | 1.33e-03 | 101 | 236 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.33e-03 | 101 | 236 | 5 | C0751123 | |
| Disease | Single Seizure | 1.33e-03 | 101 | 236 | 5 | C0751110 | |
| Disease | Visual seizure | 1.33e-03 | 101 | 236 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 1.33e-03 | 101 | 236 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 1.33e-03 | 101 | 236 | 5 | C0422855 | |
| Disease | Gustatory seizure | 1.33e-03 | 101 | 236 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.33e-03 | 101 | 236 | 5 | C0422850 | |
| Disease | Olfactory seizure | 1.33e-03 | 101 | 236 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 1.33e-03 | 101 | 236 | 5 | C0422852 | |
| Disease | Convulsive Seizures | 1.33e-03 | 101 | 236 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 1.33e-03 | 101 | 236 | 5 | C0751496 | |
| Disease | Complex partial seizures | 1.33e-03 | 101 | 236 | 5 | C0149958 | |
| Disease | Nonepileptic Seizures | 1.33e-03 | 101 | 236 | 5 | C3495874 | |
| Disease | Generalized Absence Seizures | 1.33e-03 | 101 | 236 | 5 | C4505436 | |
| Disease | Jacksonian Seizure | 1.33e-03 | 101 | 236 | 5 | C0022333 | |
| Disease | Epileptic Seizures | 1.33e-03 | 101 | 236 | 5 | C4317109 | |
| Disease | Absence Seizures | 1.39e-03 | 102 | 236 | 5 | C4316903 | |
| Disease | Convulsions | 1.39e-03 | 102 | 236 | 5 | C4048158 | |
| Disease | Tonic Seizures | 1.39e-03 | 102 | 236 | 5 | C0270844 | |
| Disease | immune system disease | 1.43e-03 | 28 | 236 | 3 | EFO_0000540 | |
| Disease | Hyalinosis, Segmental Glomerular | 1.43e-03 | 28 | 236 | 3 | C0086432 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.44e-03 | 152 | 236 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.45e-03 | 103 | 236 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | Alcoholic Intoxication, Chronic | 1.49e-03 | 268 | 236 | 8 | C0001973 | |
| Disease | Tonic - clonic seizures | 1.52e-03 | 104 | 236 | 5 | C0494475 | |
| Disease | Seizures, Focal | 1.52e-03 | 104 | 236 | 5 | C0751495 | |
| Disease | Myoclonic Seizures | 1.52e-03 | 104 | 236 | 5 | C4317123 | |
| Disease | serum metabolite measurement | TDRD15 PDE3A TRIM4 HUNK LACTB SH3BP4 PCDH15 MAP4K2 SPRYD4 TNPO1 MROH9 PYROXD2 SHBG CPS1 MAP4K5 EPHA10 EPHA7 | 1.67e-03 | 945 | 236 | 17 | EFO_0005653 |
| Disease | mannose measurement | 1.73e-03 | 8 | 236 | 2 | EFO_0006958 | |
| Disease | Endotoxemia | 1.73e-03 | 8 | 236 | 2 | C0376618 | |
| Disease | Juvenile Myoclonic Epilepsy | 1.73e-03 | 8 | 236 | 2 | C0270853 | |
| Disease | X-17676 measurement | 1.73e-03 | 8 | 236 | 2 | EFO_0800785 | |
| Disease | asymmetrical dimethylarginine measurement | 1.73e-03 | 8 | 236 | 2 | EFO_0006522 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 1.74e-03 | 64 | 236 | 4 | DOID:224 (implicated_via_orthology) | |
| Disease | gallstones | 1.79e-03 | 108 | 236 | 5 | EFO_0004210 | |
| Disease | Thyroid preparation use measurement | 1.89e-03 | 217 | 236 | 7 | EFO_0009933 | |
| Disease | histidine measurement | 1.95e-03 | 66 | 236 | 4 | EFO_0009769 | |
| Disease | metabolite measurement | TRIM4 LACTB STK10 SPRYD4 MROH9 PYROXD2 SHBG SLC17A4 CPS1 MYOF MAP4K5 EPHB1 | 1.97e-03 | 560 | 236 | 12 | EFO_0004725 |
| Disease | neuroticism measurement, cognitive function measurement | NBEAL1 GBE1 LRP1B LRFN5 SETD3 NOS1 STK24 TG ENAH GABRA1 GABRA2 EPHB1 | 2.15e-03 | 566 | 236 | 12 | EFO_0007660, EFO_0008354 |
| Disease | tauopathy (implicated_via_orthology) | 2.75e-03 | 10 | 236 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | glomerulosclerosis (biomarker_via_orthology) | 2.75e-03 | 10 | 236 | 2 | DOID:0050851 (biomarker_via_orthology) | |
| Disease | autoimmune disease | 2.77e-03 | 173 | 236 | 6 | EFO_0005140 | |
| Disease | Rheumatoid Arthritis | 2.85e-03 | 174 | 236 | 6 | C0003873 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.94e-03 | 121 | 236 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | endometrial cancer (is_implicated_in) | 2.97e-03 | 36 | 236 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | Focal glomerulosclerosis | 2.97e-03 | 36 | 236 | 3 | C0017668 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NFKGLDPNYTTWMDV | 101 | Q6UWY0 | |
| LMKLYEGAFLPSSQW | 986 | Q96L91 | |
| AIEWPGAYPKLMEID | 11 | Q92556 | |
| GWDDELRKPGAQIYM | 171 | Q9UGI9 | |
| MWISKQEYDEAGPPI | 356 | Q562R1 | |
| AIIAWMEKNPFVLGA | 746 | Q8IUX7 | |
| TDMDGNLLQWVPKYA | 601 | Q9UP79 | |
| LMWEVFSLGKQPYDL | 601 | P51813 | |
| PTAKAWKYMEEEILG | 341 | Q8NEB7 | |
| KQWKGPDDILLGMFY | 81 | Q8IX05 | |
| IELMDGDAAYVPLTW | 1451 | Q7Z2Y8 | |
| MPKGTEFGIDYNSWE | 26 | Q9Y312 | |
| LNGKQEVYTAWPMAG | 91 | Q8NB90 | |
| PEKYAQWSAGIALMK | 201 | P50052 | |
| VMNYWKDNGAPAEKL | 246 | Q9BZP6 | |
| LWKPSDTAMLASYAV | 231 | P30038 | |
| EDSVSRMKPWQSEYG | 486 | O60306 | |
| GADYAEPTWNLKDLM | 421 | P15144 | |
| YEFLQSWGPQKLEDM | 721 | Q96M86 | |
| LPYDLEDAMVFWINK | 181 | Q5T5Y3 | |
| RPGWMEKGEYDLVSA | 51 | Q8TE57 | |
| VAWEYSMPRLGTEKQ | 851 | Q8TE57 | |
| DIPGWVAEEMAKLEY | 866 | Q9HCE9 | |
| WQALMDNPYDVKELI | 2141 | Q6ZS30 | |
| GWKQSEDAMPVINYD | 156 | Q9UKA8 | |
| ESTMYPKAVQDLCGW | 416 | Q9P258 | |
| YWGELHDPIKATEIM | 16 | Q6UY27 | |
| DYTWMLLKDGIIPEN | 241 | Q9Y2R2 | |
| YWPTDDQEMLFKETG | 126 | P17706 | |
| YNNLETIPWDAVEKM | 156 | Q96NI6 | |
| YWMAPEVAAVERKGG | 176 | Q12851 | |
| LRAGQLSYKEDPMGW | 1701 | Q9H1A4 | |
| LSYKEDPMGWQSLLA | 1706 | Q9H1A4 | |
| ELELKWYALPAVANM | 341 | P35228 | |
| WYALPAVANMLLEVG | 346 | P35228 | |
| QMPKKDWYSILGADP | 6 | Q6P3W2 | |
| IKLYCNGDGEWMVPI | 236 | P54762 | |
| LSAQGKMPWIEYNHE | 141 | Q5TGI0 | |
| ALMGKYDQWEESPPL | 2346 | Q9Y618 | |
| YWMAPEVAAVERKGG | 176 | Q8IVH8 | |
| LPELKDAVLDQYSMW | 161 | Q9H8M7 | |
| GNYWTLDPNCEKMFD | 216 | A8MTJ6 | |
| RKPYTSAVDMWALGV | 236 | Q96QS6 | |
| LENYFKPSMLEDPWA | 136 | Q8TAP9 | |
| PDTNKYEGWPELLEM | 201 | Q96BQ1 | |
| LYMTWDPALAQIAKA | 56 | P48060 | |
| FAYPMASIEWRKDGL | 196 | Q96I82 | |
| LKIEPSSNWDMTGYG | 31 | Q9H2X6 | |
| TIYKDMKTGAWPNGL | 1416 | Q9NZR2 | |
| NIGLAAWEEYPTLKM | 751 | Q8N201 | |
| IIYWAKEDGMLPKNR | 301 | Q92823 | |
| LLKAMGWQEYPENDE | 391 | Q9HC44 | |
| KWDEMNILATYRPAD | 46 | Q96PQ5 | |
| GPEDMDYSVKIKFSW | 236 | Q8N370 | |
| LYTMKGPDWNTELYN | 786 | P46020 | |
| YALFKDGIQPMWEDS | 116 | A6NMX2 | |
| PVPNTEMSWDKEGKY | 446 | P83111 | |
| EKEYATSGWNLNVMP | 456 | Q9BY66 | |
| NADISGMKVPWLYVG | 481 | Q9BY66 | |
| RKPYTNSVDMWALGV | 271 | P11801 | |
| MFWVYLATQGVNPKE | 66 | Q13901 | |
| DVPKMYCGADGEWLV | 241 | P54764 | |
| GERPYWDMSNQDVIK | 821 | P54764 | |
| GKGNYWTLDPNCEKM | 171 | Q6ZQN5 | |
| RNSLPKVAYATAMDW | 301 | P47869 | |
| WADPGKYALMGAAAQ | 541 | P51798 | |
| GCYDMWTVIAPVRKE | 531 | Q10570 | |
| KGNYWMLDPSSDDVF | 251 | P55316 | |
| EKMGIYLAEPQWAVR | 56 | Q9NYQ8 | |
| SMYPGLIWENEEKSM | 21 | Q02556 | |
| ELGYAMASPNALVLW | 716 | Q9ULD0 | |
| PNNYTKAIDMWAAGC | 206 | Q16659 | |
| KGYVDDPRNTDNAWM | 266 | Q9BW91 | |
| SDMKGSYPVWEDFIN | 21 | O43312 | |
| YDSAGLMPGKWVEDS | 1016 | Q14432 | |
| SKLMERELNPYWKDG | 191 | Q2TBE0 | |
| VPVLASWKEQGYDKM | 71 | Q5W188 | |
| PYDAMWLDIEHTEGK | 391 | Q8TET4 | |
| PEISKSYGMNEWRED | 2281 | Q6ZR08 | |
| SNDIWIMGRKEPDSY | 251 | Q8IV20 | |
| RNSLPKVAYATAMDW | 326 | P34903 | |
| RNSLPKVAYATAMDW | 301 | P14867 | |
| PKVSYATAMDWFIAV | 311 | P48169 | |
| LPKVAYATAMDWFIA | 311 | P31644 | |
| KIQDMSGWYLTDLPG | 536 | P24043 | |
| YNLDSKLKMPEWIGG | 151 | Q15040 | |
| PYWDMSGQDVIKAVE | 846 | Q5JZY3 | |
| LVNADAPYWLVGMTE | 226 | Q7Z3U7 | |
| MSKDAYVPMAAGSWI | 136 | Q8NGS8 | |
| MSKDAYVPMAAGSWI | 136 | Q8NGS9 | |
| QKLWEVVHAAVPGYM | 301 | Q6ZWE6 | |
| AADAWAAPIAMQIYK | 461 | P51617 | |
| YLKWMAEGGKDQQLP | 691 | Q495T6 | |
| DYPVPADDTLIQMWK | 336 | Q5TGP6 | |
| PYWDMSNQDVIKAIE | 836 | Q15375 | |
| GKMPEVDYVVLSEWF | 151 | O00142 | |
| KWDEMNILATYHPAD | 46 | P41236 | |
| WYKDGQPIMSSSQAL | 1581 | Q96RW7 | |
| DLGLKWYGLPAVSNM | 561 | P29475 | |
| NGDVWKVHEVPDYSM | 441 | Q96T49 | |
| DIMYNLFDWPTHKEA | 631 | Q13415 | |
| HSNKYEGWPEALEME | 206 | P98173 | |
| SWLKDDEPLYIGNRM | 556 | O94856 | |
| VVMTYWTNFAKTGDP | 556 | Q9NZ94 | |
| ENWALPVMYAVALDL | 101 | Q5JVF3 | |
| YSPKMEDWAGVNRTA | 316 | P15863 | |
| EKGPQYGTVEKAWMA | 71 | Q9UNF0 | |
| SLKDNVDYWVLMDPV | 76 | Q96QU1 | |
| IEMWSYAAKVAPADG | 1116 | Q92896 | |
| EADPYSKWAILNVMG | 1051 | Q13315 | |
| PWNHDFTKMEYDGIL | 246 | P31327 | |
| QLMEGDKVYWPTQSA | 1766 | Q3L8U1 | |
| FDYRLAMAIPDKWIQ | 431 | Q04446 | |
| KRPDNENGWMSYLSE | 241 | O95838 | |
| YDPVADQWEFKAPMS | 481 | Q53HC5 | |
| FKDLIGKNVYPGDWM | 976 | Q92608 | |
| AYEFSIKSEEWMNGP | 876 | Q8TD57 | |
| LDPYNAFLSAVKWIM | 921 | Q8IZS8 | |
| VLAKLYEADMDLWAP | 726 | Q9HBT6 | |
| MDLPGLNLPDSWKTY | 501 | Q6ZNA5 | |
| DTPKMYCSAEGEWLV | 241 | P29322 | |
| GELSIENWIMPAVYA | 76 | Q49AR2 | |
| KTESDYIWDQLMANP | 781 | Q2V2M9 | |
| GPKIDVWSIGVNMYA | 241 | P57058 | |
| WLKPVYMLDSDPDNN | 236 | Q9NV96 | |
| KSDWPEGYQLASSMN | 221 | P20794 | |
| YGAEWPKVGATLALM | 81 | Q9NZD2 | |
| MQLDKQTYHPVGAWD | 126 | Q86SG7 | |
| DMDVEPSWKYTAIGC | 621 | O60336 | |
| FSVEMPLTGKAYLWA | 621 | Q8WUQ7 | |
| MADDSLWKPLNYQIL | 2056 | Q9H583 | |
| AAVMVYDDANKKWVP | 11 | Q8N8S7 | |
| NFLIGPKLYEANWME | 481 | P19447 | |
| YWTLDPNCEKMFDNG | 196 | Q12951 | |
| AKQEVPSWLENMAYE | 561 | O15523 | |
| ELLLGAPYGKSVDMW | 181 | O76039 | |
| AMEPCLDGWVYNSTK | 91 | Q8TCC7 | |
| FKAMAPAYDWSPEIQ | 96 | Q9Y2C5 | |
| TQGLWEKVMPSRYAA | 316 | O60779 | |
| AMKITQEPQGLGYWE | 181 | Q8IXA5 | |
| TQYGTETLWSKDMAP | 136 | Q9NZJ4 | |
| SAAGTYAWMAPEVIK | 281 | Q16584 | |
| NDFISMDPKVGWGAV | 176 | Q96HA8 | |
| MDPKVGWGAVYTLSE | 181 | Q96HA8 | |
| KGNYWTLDPQSEDMF | 211 | Q9UJU5 | |
| LTEKPPWAEYEAMAA | 561 | Q99759 | |
| PWAEYEAMAAIFKIA | 566 | Q99759 | |
| WMAPEVAAVEKNGGY | 181 | Q9Y4K4 | |
| YVKWMLGAEDLTPED | 266 | P23468 | |
| WAQSFENLMATKYGP | 31 | O14921 | |
| DPSQDQWSVRAPMKY | 466 | Q3ZCT8 | |
| LYKELMGPWNKDEIS | 101 | P05121 | |
| LAWDGASAVYIKMSP | 261 | Q6ZRI0 | |
| LWMKDVSQELDPDLY | 171 | Q05084 | |
| VLMWEVFSEGKIPYE | 546 | Q08881 | |
| AWYMPADKALVDSAD | 1226 | Q10571 | |
| MASIYAAWLGQDVVP | 286 | Q8NH67 | |
| GKGNYWTLDPESADM | 196 | O60548 | |
| PYWMAPEVAAVALKG | 176 | Q92918 | |
| EGKVWDYMACQPEST | 41 | Q9Y2I2 | |
| KPYMGNNDLTMWLGE | 471 | Q9H720 | |
| WKPGYLDRALQVMEK | 251 | Q92552 | |
| TVMPAWVIDKYGKNE | 41 | Q8WWV3 | |
| MDIGGTSDPYVKVWL | 296 | O43581 | |
| LGLPAYRKFDIEAWM | 396 | Q9NP81 | |
| AAAQMIGWYDPKVTR | 421 | P54136 | |
| AQFAAYWKPVLSMDA | 556 | Q5T011 | |
| AGQWLYEEKPHKMDL | 196 | Q6ZV65 | |
| TMEKPFQYTAWELTG | 876 | Q5TCS8 | |
| LNIKYAMDAFGGPIW | 91 | Q969X6 | |
| YDVVLDSKLDEWMPT | 181 | Q9NYK5 | |
| KGLFYCMWVQDEPLL | 56 | Q14684 | |
| WYTMLANEKAPVEGI | 131 | Q8WW59 | |
| VDSEAMWKPAYDFLL | 886 | Q9P0V3 | |
| IAMAVLGYWPQKEHF | 76 | Q86VY9 | |
| AMQDALADLPEWYGI | 251 | Q15031 | |
| LADLPEWYGIKGMQA | 256 | Q15031 | |
| WMPVDLYIGGKEHAV | 551 | Q15031 | |
| PNQVKIWFMDYGSSE | 316 | B5MCY1 | |
| FWMAPEVIKQSAYDS | 196 | Q9Y6E0 | |
| IPYEEFLGQGWMKLD | 1021 | O14827 | |
| KGNYWTLDPAAADMF | 141 | Q13461 | |
| PQAASIYQSSEMKGW | 1351 | Q9Y6Q9 | |
| DWRLYLFQAPTAKEM | 866 | Q8NDX1 | |
| PMDYAWGANGLDAII | 176 | Q9BV68 | |
| YGDTNPKDDWFMLGL | 86 | P04278 | |
| EDYFPDLMKWASENG | 76 | Q86TU7 | |
| SKAMTGVEQWPYRAV | 426 | P49368 | |
| EGQHFWEIKMTSPVY | 146 | Q6PJ21 | |
| EEPARISWKQYMSGS | 3476 | Q9P2P6 | |
| MYDNELWAPASEGLK | 181 | Q9UHV2 | |
| MCEKSYIEAREGWPL | 381 | Q7Z745 | |
| AIADWYNEKGGMALA | 151 | P10155 | |
| VSKYGDLANWMIPGK | 401 | Q9BYC2 | |
| ASTVIAYAMKEFGWP | 401 | Q8WYL5 | |
| QYLPHADWIIAMKDG | 891 | Q09428 | |
| MIAYDAVLAAGDSWK | 276 | P54922 | |
| KTDWPEGYQLSSAMN | 221 | Q9UPZ9 | |
| AVYHWSMEGESQPVK | 126 | Q00610 | |
| KIFNGIPDWVYEEEM | 191 | Q12884 | |
| PKYWGRAFIMGDVAL | 71 | Q7RTY3 | |
| FVGISNWALDPAKMN | 2881 | Q63HN8 | |
| EVTKLQYNSSEWMPG | 961 | Q8N2E2 | |
| EMYGDIQPAAWELLL | 1586 | Q8N2C7 | |
| GAWYPLLKNISMDET | 2166 | Q8NB66 | |
| MPYTLAGGKAWDEQE | 461 | Q8N2H3 | |
| LKPDAEYPEWLFEMN | 86 | Q6P161 | |
| PSYSLQWLKMDFVAG | 41 | Q86WA9 | |
| SASDIAKHVYDNWPM | 31 | O95164 | |
| WPSFENLLKCGMEVY | 1411 | O94759 | |
| KGYMDDPRNTDNAWI | 1426 | O94759 | |
| TWYAMAKKDPEGLFL | 41 | P02753 | |
| LQKRDSFIGTPYWMA | 186 | O94804 | |
| MAELYVKPGNKERGW | 1 | Q9HD15 | |
| EDEHYPLWKSVIGGM | 121 | O95847 | |
| MKPLWIMYSNEEAGS | 756 | O00329 | |
| WKQEGLDLRMTPYGC | 801 | O00329 | |
| DLVNLMSNYDVPEKW | 176 | O75116 | |
| LWMTPDQRGKGLYAD | 136 | Q86V40 | |
| TWVTGKEPLTYYDMN | 171 | Q8TDW4 | |
| ANEKVTSDADPMWYL | 61 | Q9NW08 | |
| KSVWELEGMPQDTYS | 721 | Q2KHR2 | |
| TLMGEDVWSYAKGLP | 901 | Q96JH7 | |
| YAVDLMLKWDNGPDG | 581 | Q14166 | |
| FIFLEMKDYIPGAWA | 796 | Q00722 | |
| MKDYIPGAWADLTVA | 801 | Q00722 | |
| QTKMEYEWKPDEQGL | 6 | Q92973 | |
| LNTWTNRYPDAKMDP | 3161 | P78527 | |
| LVNLMSNYDVPEKWA | 161 | Q13464 | |
| SMDAENEPKVWYVSL | 106 | Q7Z3V4 | |
| AIKALPTDWLIYDEM | 1026 | Q9H6S0 | |
| EIKTFMPIAWAAAYG | 351 | P17010 | |
| GMFEAWYEKIAQEDP | 1746 | O43149 | |
| YAILGMNWFSKVNPE | 1511 | Q9UI33 | |
| MEEKPYKWNGSEIAF | 236 | P17014 | |
| QGPKEYLFELWNMLD | 516 | Q9Y210 | |
| DRSKMSPDVGIWAIY | 406 | Q9C037 | |
| ILKGWMNEIYNYDPE | 546 | Q8IWB9 | |
| WNGDKYLGPAVLMQA | 201 | P21912 | |
| EGNRNKCAEYWPSME | 756 | P08575 | |
| QQVYLWKDSDMGSRP | 1816 | P01266 | |
| VMFGETPSWDLEQKY | 306 | O95801 | |
| LSPEKEIYEMESLQW | 56 | Q7Z3V5 | |
| DPVQKALYWDVMLEN | 26 | Q6ZNA1 | |
| QWKDGEINYKEVPMT | 101 | Q6ZNA1 | |
| DEMKTFVPIAWAAAY | 346 | P08048 | |
| ATVMLYDDGNKRWLP | 11 | P50552 | |
| PSIKWCGAEGDYNVM | 66 | P49674 | |
| YDPRSNSWAEIAPMK | 371 | Q96NJ5 | |
| NADISGMKVPWLYVG | 491 | P41229 | |
| QAWEMKPYVEVAIGK | 481 | Q92802 | |
| EMSDIYVKGWIPGNE | 1811 | Q9NZM1 | |
| ADYADFMKGIGWLPL | 1926 | P20929 |